Skip to main content

Table 2 Critical Congenital Heart Defects’ prevalence by some sociodemographic characteristics, Turkey, 2018–2020

From: Evaluation of critical congenital heart disease from 2018 to 2020 in Turkey: a retrospective cohort study

Variables

CCHD, n (%)*

CCHD, prevalence**

n

9884

27.8

Gender

  

 Male

5485 (55.5)

30.0a

 Female

4399 (44.5)

25.4b

Maternal age at birth

  

 < 20 years

404 (4.1)

25.1a

 20–34 years

7170 (72.5)

25.6a

 ≥ 35 years

2250 (22.8)

39.8b

 Unknown

60 (0.6)

 

Number of fetuses in pregnancy

  

 Singular

9305 (94.1)

27.1a

 Twin/triplet

474 (4.8)

42.5b

 Unknown

110 (1.1)

 

Gestational age***

  

 ≥ 37 weeks

7620 (77.1)

24.1a

 < 37 weeks

2155 (21.8)

55.0b

 Unknown

109 (1.1)

 

Birth weight***

  

 ≥ 2500 gram

7497 (75.8)

22.8a

 < 2500 gram

2278 (23.0)

83.1b

 Unknown

109 (1.1)

 

Mode of delivery***

  

 Normal

3208 (32.4)

22.7a

 Cesarean

6332 (64.1)

29.5b

 Unknown

344 (3.5)

Regions

  

 West

3814 (38.6)

29.5a

 South

1288 (13.0)

28.5a

 Central

1826 (18.5)

28.2a

 North

549 (5.6)

30.3a

 East

2352 (23.8)

24.0b

 Unknown

55 (0.6)

  1. a.b Different letters in the same column are statistically significant (p < 0.001)
  2. *column percentage
  3. **1/10,000 live birth;
  4. ***The data for gestational age, birth weight, delivery type was only available in the 2020 Birth Notification System. In order to estimate the number of live births according to gestational age, birth weight and mode of delivery, the 2018–2020 relative percentages of these variables were calculated with the 2020 distributions. Then, CCHD prevalence were estimated with this values. Live birth data for other parameters were present in 2018–2020